Onfekafusp alfa

N/A

Report date: 2023/07/12 14:18:39

Base Information

Drug NameOnfekafusp alfa
Drug Alias NameL19-TNFonfekafusp alphaL19 TNF fusion proteinL19-TNF-alphaL19-hTN +[8] 
ClassificationBiologics > Protein drugs > Recombinant protein > Fusion protein > Fc fusion protein
Mechanisms of ActionTumor necrosis factor receptor agonistsFibronectin inhibitorsImmunostimulants +[4] 
TargetsTumor necrosis factor receptorFibronectin
Therapy Area/IndicationsSolid tumoursGenital Neoplasms, FemaleLung Neoplasms +[9] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesPolandItaly +[7] 
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaN/A
Originator CompaniesPhilogen Spa
China Registration ClassN/A

Develop Information

Active CompaniesPhilogen Spa
Inactive CompaniesN/A
Active IndicationsMelanomaGlioblastomaGlioma +[4] 
Inactive IndicationsSolid tumoursGenital Neoplasms, FemaleLung Neoplasms +[5] 

Other Information

ATC CodeN/A
Related LinksN/A